AVITA Medical (RCEL) Profit After Tax (QoQ) (2018 - 2025)
AVITA Medical (RCEL) Profit After Tax (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | AVITA Medical | 132.90 Mn | 116.55 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.88% |
| Sep 30, 2025 | -32.93% |
| Jun 30, 2025 | 28.42% |
| Mar 31, 2025 | -19.59% |
| Dec 31, 2024 | 28.49% |
| Sep 30, 2024 | -5.28% |
| Jun 30, 2024 | 17.50% |
| Mar 31, 2024 | -164.09% |
| Dec 31, 2023 | 18.90% |
| Sep 30, 2023 | 16.10% |
| Jun 30, 2023 | -12.62% |
| Mar 31, 2023 | 5.69% |
| Dec 31, 2022 | -74.95% |
| Sep 30, 2021 | -55.51% |
| Jun 30, 2021 | -78.67% |
| Mar 31, 2021 | -6.31% |
| Dec 31, 2020 | 44.84% |
| Sep 30, 2020 | 20.81% |
| Jun 30, 2020 | 14.18% |
| Mar 31, 2020 | -43.29% |